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Abstract
 
Mice deficient in interferon (IFN)-
 
g
 
 or IFN-
 
g
 
 receptor develop progressive and fatal experi-
mental autoimmune encephalomyelitis (EAE). We demonstrate that CD4 T cells lacking IFN-
 
g
 
production were required to passively transfer EAE, indicating that they were disease-medi-
ating cells in IFN-
 
g
 
 knockout (KO) mice. IFN-
 
g
 
 KO mice accumulated 10–16-fold more ac-
tivated CD4 T cells (CD4
 
1
 
CD44
 
hi
 
) than wild-type mice in the central nervous system during
EAE. CD4
 
1
 
CD44
 
hi
 
 T cells in the spleen and central nervous system of IFN-
 
g
 
 KO mice during
EAE showed markedly increased in vivo proliferation and significantly decreased ex vivo apop-
 
tosis compared with those of wild-type mice. IFN-
 
g
 
 KO CD4
 
1
 
CD44
 
hi
 
 T cells proliferated
extensively to antigen restimulation in vitro and accumulated larger numbers of live CD4
 
1
 
CD44
 
hi
 
 T cells. IFN-
 
g
 
 completely suppressed proliferation and significantly induced apoptosis
of CD4
 
1
 
CD44
 
hi 
 
T cells responding to antigen and hence inhibited accumulation of live, acti-
vated CD4 T cells. We thus present novel in vivo and in vitro evidence that IFN-
 
g
 
 may limit
the extent of EAE by suppressing expansion of activated CD4 T cells.
Key words: T lymphocytes • apoptosis • autoimmune diseases • animal disease models • 
knockout mice
 
Introduction
 
The role of IFN-
 
g
 
 in experimental autoimmune encepha-
lomyelitis (EAE) was originally thought to be pathogenic
(1). However, a large body of evidence has accumulated to
indicate a suppressive rather than pathogenic role for IFN-
 
g
 
in EAE. Thus, administration of anti–IFN-
 
g
 
 Ab (1) or in-
activation of either the IFN-
 
g
 
 or IFN-
 
g
 
R gene leads to
exacerbation of disease in susceptible strains of mice and
conversion of mice from being resistant to being highly
susceptible to EAE (2–4). Administration of IFN-
 
g
 
 to mice
with EAE can inhibit the disease and prevent further re-
lapses (1).
Previous in vitro studies have reported immunosuppres-
sive activities of IFN-
 
g
 
. For example, we have shown that
T cells from IFN-
 
g
 
 knockout (KO) mice display markedly
increased in vitro proliferation to Con A and to alloanti-
gens, suggesting a critical role of IFN-
 
g
 
 in suppressing T
cell proliferation (5). Anti–IFN-
 
g
 
 Ab enhanced in vitro
proliferation of cloned T cells or T cell lines specific to my-
elin proteins (6, 7). IFN-
 
g
 
 KO lymph node and IFN-
 
g
 
R
KO spleen cell cultures showed enhanced proliferation to
Ag restimulation in vitro (2, 8, 9). An earlier study reported
that IFN-
 
g
 
 is required for anti-CD3–induced cell death of
cloned T cells (10). However, none of these studies ad-
dressed whether mice lacking an IFN-
 
g
 
 response have in-
creased in vivo T cell proliferation, or decreased T cell ap-
optosis, or whether this results in accumulation of T cells in
vivo.
As EAE is mediated by CD4 T cells (1), we investigated
the in vivo proliferation and apoptosis of activated CD4 T
cells in IFN-
 
g
 
 KO mice to determine whether IFN-
 
g
 
 has
an in vivo role in controlling the expansion of CD4 T cells
during EAE. We report here that activated CD4 T cells in
the spleen and central nervous system (CNS) of IFN-
 
g
 
 KO
mice proliferate more and undergo decreased apoptosis
compared with those in wild-type mice. Thus, IFN-
 
g
 
 KO
mice accumulate large numbers of activated CD4 T cells in
the spleen and CNS during EAE. We further demonstrate
that IFN-
 
g
 
 prevents accumulation of activated CD4 T cells
in response to in vitro Ag stimulation by both inhibiting
proliferation and inducing apoptosis of CD4 T cells.
 
Address correspondence to Dyana K. Dalton, The Trudeau Institute, 100
Algonquin Ave., P.O. Box 59, Saranac Lake, NY 12983. Phone: 518-891-
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Materials and Methods
 
Immunization of Mice.
 
Homozygous IFN-
 
g
 
 KO C57BL/6
mice were generated by backcrossing 10 generations of the origi-
nal IFN-
 
g
 
 KO mice onto C57BL/6 background (5). Wild-type
C57BL/6 mice were used as controls. 6–10-wk-old mice were
injected subcutaneously at the base of the tail with 100 
 
m
 
g of
mouse myelin oligodendrocyte glycoprotein peptide 35–55
(MOG
 
35–55
 
; Genosys Biotechnologies) in CFA containing 5 mg/
ml of killed 
 
Mycobacterium
 
 
 
tuberculosis
 
 (H37Ra) and 0.5 mg/ml 
 
M.
butyricum
 
 (Difco Labs.). Mice were also injected intraperitoneally
with 200 ng of pertussis toxin (List Biological Labs.). Mice were
given an identical booster on day 7 of initial immunization.
 
Adoptive Transfer of EAE.
 
Spleen cells from MOG
 
35–55
 
-immu-
nized mice were cultured with 10 
 
m
 
g/ml MOG
 
35–55
 
 for 48 h in T
cell medium (RPMI 1640 with 7.5% FCS, 0.01 M Hepes, 5 
 
3
 
10
 
2
 
5
 
 M 2-ME, 0.292 mg/ml glutamine, and antibiotics) and 80
U/ml of recombinant murine IL-2 (R & D Systems). CD4 T
cells were depleted from cultured spleen cells using a MACS™
magnetic separation column (Miltenyi Biotec). Routinely, 99%
depletion of CD4 T cells was achieved. 50 million whole spleen
cells or CD4 T cell–depleted spleen cells were injected intrave-
nously into each mouse.
 
Isolation of Mononuclear Cells from CNS.
 
Mononuclear cells in
the CNS were isolated using gradient centrifugation as described
(11). In brief, mice were perfused with 20 ml of PBS via the ret-
roorbital veins to eliminate peripheral blood. The dissociated
CNS tissue was centrifuged in a Percoll gradient. Mononuclear
cells at the interface of 70–37% Percoll were collected and stained
for phenotype analysis.
 
In Vivo 5-Bromo-2
 
9
 
-Deoxyuridine Uptake.
 
Mice were injected
intraperitoneally with 0.8 mg of 5-bromo-2
 
9
 
-deoxyuridine
(BrdU; Sigma-Aldrich) four times within 48 h. Spleen cells and
CNS mononuclear cells were stained with anti-CD4–Cy-
Chrome and anti-CD44–PE (PharMingen). Stained cells were
fixed in 70% ethanol, resuspended in 1% paraformaldehyde con-
taining 0.01% Tween-20. The cells were treated with 50 Kunitz
units/ml DNase and incubated with 0.25 
 
m
 
g of anti-BrdU–FITC
(B44; Becton Dickinson). BrdU incorporation was analyzed on
gated CD4
 
1
 
CD44
 
hi
 
 T cells.
 
Apoptosis Assay.
 
For ex vivo detection of apoptosis, freshly
isolated spleen cells and CNS mononuclear cells were stained as
described below. For in vitro induction of apoptosis, spleen cells
from MOG
 
35–55
 
-immunized mice were cultured at 5 
 
3
 
 10
 
6
 
/ml
(0.2 ml/well) in 96-well plates with MOG
 
35–55 
 
in T cell medium
and IL-2 (80 U/ml). IFN-
 
g
 
 (50 ng/ml; R & D Systems) or anti–
IFN-
 
g
 
 mAb (clone XMG1.2, rat IgG
 
1
 
; American Type Culture
Collection; 10 
 
m
 
g/ml) was added at the beginning of cultures. A
rat IgG
 
1
 
 (antiperoxidase; from C. Dean, Institute of Cancer Re-
search, Surrey, UK) was used as an isotype control for anti–IFN-
 
g
 
mAb. At various time points, cells were stained with anti-CD4–
allophycocyanin and anti-CD44–PE and resuspended in annexin
binding buffer. The cells were stained for 15 min with 0.05 
 
m
 
g of
FITC-labeled annexin V (R & D Systems) at room temperature.
Immediately before collection, 0.25 
 
m
 
g of propidium iodide (PI)
was added. Apoptosis was analyzed on gated CD4
 
1
 
CD44
 
hi
 
 T
cells.
 
Cell Labeling with Carboxyfluorescein Succinimidyl Ester and In
Vitro Proliferation of CD4 T Cells.
 
Splenic CD4 T cells were pu-
rified using magnetic beads conjugated with anti-CD4 Ab and a
magnetic column (Miltenyi Biotec). Purified CD4 T cells (90–
95% purity) were labeled with carboxyfluorescein succinimidyl
ester (CFSE; Molecular Probes) as described (12). Labeling effi-
ciency exceeded 99%. CFSE-labeled, purified CD4 T cells were
 
cultured in T cell medium (10
 
5
 
/well) with either CD4 T cell–
depleted spleen cells (4 
 
3
 
 10
 
5
 
/well) or activated B cells (4 
 
3 
 
10
 
5
 
/
well) as APCs. Cells were cultured in T cell medium alone or
containing MOG
 
35–55
 
 or human osteocalcin peptide (OC
 
7–19
 
).
Cells were harvested at time points indicated (see Fig. 4) and
stained with anti-CD4–allophycocyanin and anti-CD44–PE.
CFSE fluorescence profile was analyzed on gated CD4
 
1
 
CD44
 
hi
 
 T
cells.
 
Results
 
CD4 T Cells Were Required for Adoptive Transfer of EAE in
IFN-
 
g
 
 KO Mice.
 
Consistent with previous studies on the
course of EAE in mice lacking IFN-
 
g
 
 or IFN-
 
g
 
R (2–4),
we found that IFN-
 
g
 
 KO C57BL/6 mice were highly sus-
ceptible to MOG and myelin basic protein–induced EAE
and had a chronic, progressive, and more severe course of
disease than wild-type mice (data not shown).
Most CD4 T cell lines that passively transfer EAE make
IFN-
 
g
 
 (1). To determine whether CD4 T cells that are de-
ficient in IFN-
 
g
 
 production function as effector cells in
EAE, we tested whether CD4 T cell–depleted spleen cells
can passively transfer EAE. In both wild-type and IFN-
 
g
 
KO recipients, mice that received whole spleen cells devel-
oped EAE (Fig. 1), while depletion of CD4 T cells from
spleen cells completely abolished the transfer of EAE in
both wild-type and IFN-
 
g
 
 KO mice (Fig. 1). These results
clearly indicate that in IFN-
 
g
 
 KO mice, CD4 T cells are
required for passive transfer of EAE and suggest that they
are effector cells in actively induced EAE.
 
Increased In Vivo Accumulation of Activated CD4 T Cells in
IFN-
 
g
 
 KO Mice with EAE.
 
The kinetics of accumulation
of activated CD4 T cells was followed during the course of
EAE. Ag-experienced CD4 T cells express high levels of
CD44 after activation (13). We used CD44
 
hi
 
 expression as
Figure 1. CD4 T cells from
IFN-g KO mice were required
for adoptive transfer of EAE.
Whole spleen cells from
MOG35–55-immunized mice
were restimulated with 10 mg/
ml MOG35–55 for 48 h. 50 mil-
lion whole spleen cells or CD4 T
cell–depleted spleen cells were
transferred into naive mice
(wild-type cells to wild-type and
IFN-g KO cells to IFN-g KO
recipients). Development of EAE
was monitored for 5 wk (pooled
results of two experiments). 
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a marker for activated CD4 T cells. CD4 T cells that were
CD44
 
hi
 
 were also CD45RB
 
low
 
 and CD62L
 
low
 
. This is con-
sistent with an activated phenotype (14). 2 wk after immu-
nization, the population of CD4
 
1
 
CD44
 
hi
 
 T cells in the
spleen markedly increased from an average of 20% of CD4
T cells to 38% in wild-type and to 57% in IFN-
 
g
 
 KO
mice. The extent of the increase in absolute number of
CD4
 
1
 
CD44
 
hi T cells was greater in IFN-g KO mice. Ap-
proximately threefold more CD41CD44hi T cells were
found in the spleens of IFN-g KO than wild-type mice
(Fig. 2 A). At all time points after immunization, the num-
ber of splenic CD41CD44hi T cells in IFN-g KO mice was
significantly greater than that in wild-type mice (Fig. 2 A).
More strikingly, the difference in the number of acti-
vated CD4 T cells between IFN-g KO and wild-type mice
was much greater in the CNS than in the spleen. In the
CNS of IFN-g KO mice, 70–95% of CD4 T cells were
CD44hi, compared with 50–70% of CD4 T cells in wild-
type mice (Fig. 2 B). 3 wk after immunization, the absolute
number of CD41CD44hi T cells in the CNS of IFN-g KO
mice was 16-fold greater than in wild-type mice (Fig. 2 C).
The number of CD41CD44hi T cells in the CNS of mice
with EAE decreased with time of disease in both wild-type
and IFN-g KO mice but diminished with delayed kinetics
in IFN-g KO mice. At 4 wk of immunization, there were
13-fold more CD41CD44hi T cells in the CNS of IFN-g
KO mice, and at 10 wk, there were 10-fold more than in
wild-type mice (Fig. 2 C).
Increased In Vivo Proliferation of CD41CD44hi T Cells in
IFN-g KO Mice during EAE. IFN-g has been shown to
inhibit proliferation of T cells in vitro (5–7). A unique tool,
the IFN-g KO mice have allowed us to extend these in
vitro observations in vivo to explore the effect of IFN-g on
CD4 T cells in a CD4 T cell–mediated disease. We investi-
gated the in vivo proliferation of CD41CD44hi T cells dur-
ing EAE using a BrdU assay. Compared with wild-type
mice, the spleen and CNS of IFN-g KO mice had a signifi-
cantly higher percentage of CD41CD44hi T cells incorporat-
ing BrdU (Fig. 3 A), indicating that they were proliferating
in vivo. This gave rise to a greater number of proliferating
CD41CD44hi T cells in the spleen and CNS in IFN-g KO
mice during EAE. Between 2 and 4 wk after immunization,
the number of CD41CD44hi T cells incorporating BrdU in
IFN-g KO mice was 2.5–5-fold in the spleen and 4.8–6-fold
in the CNS of that in wild-type mice.
Decreased Apoptosis of Activated CD4 T Cells in the CNS of
IFN-g KO Mice with EAE. Another possible mechanism
for controlling expansion of activated CD4 T cells in the
CNS is apoptosis of this population. We have found that
IFN-g KO mice failed to induce apoptosis of activated
CD4 T cells during infection with M. bovis Bacillus Cal-
mette-Guérin (BCG) (15). This prompted us to consider
this possibility in this EAE model. Freshly isolated spleen
cells and mononuclear cells from the CNS of mice with
EAE were analyzed for apoptosis using an annexin/PI flow
cytometric assay. In the spleen at 14 and 21 d after immuni-
zation, IFN-g KO mice had a significantly lower percentage
of CD41CD44hi T cells that were apoptotic compared with
those in wild-type mice (Fig. 3 B). Additionally, IFN-g
KO mice had a significantly lower percentage of CD41
CD44hi T cells that were apoptotic in the CNS. On day 28
after immunization, there were 20 6 3.4% apoptotic
CD41CD44hi T cells in the CNS of wild-type mice com-
pared with 11.5 6 1% apoptotic in the CNS of IFN-g KO
mice (Fig. 3 B).
Thus, in vivo activated CD4 T cells of IFN-g KO mice
responding to MOG35–55 immunization displayed increased
in vivo proliferation and decreased apoptosis. This likely
contributes to the increased number of activated CD4 T
cells seen in IFN-g KO mice during EAE.
Figure 2. IFN-g KO mice accumulated a larger number of activated CD4 T cells in the spleen
and CNS during EAE. The absolute number of live CD41CD44hi T cells was determined based
on total numbers of live cells and percentage of CD41CD44hi T cells analyzed by flow cytometry.
(A) Kinetics of accumulation of CD41CD44hi T cells in the spleens of IFN-g KO mice. (B) The
CD4 T cells in the CNS in IFN-g KO mice with EAE were more skewed toward the activated
phenotype (CD44hi) compared with those in wild-type mice. CD4 T cells from mice on day 21
of immunization were analyzed. The marker of CD44hi on CD4 T cells in mice with EAE was set
up based on expression of CD44 on splenic CD4 T cells in an unimmunized wild-type mouse.
(C) Kinetics of accumulation of CD41CD44hi T cells in the CNS of IFN-g KO mice during
EAE. Pooled results of three experiments (n 5 6–10 at each time point).126 Suppressive Role of IFN-g in Experimental Autoimmune Encephalomyelitis
Enhanced Response of IFN-g KO CD4 T Cells to MOG35–55
In Vitro and Inhibition by IFN-g. Consistent with previous
findings (2, 9), we observed markedly enhanced prolifera-
tion of IFN-g KO spleen cells to MOG35–55 restimulation
in vitro and unresponsiveness of wild-type cells (Fig. 4 A).
We considered that APCs in the spleens of wild-type
mice might be suppressing CD4 T cell proliferation and
used MOG35–55-pulsed, LPS-activated B cells as APCs to
stimulate wild-type CD4 T cells. In contrast to CD4 T
cells cultured with their own spleen cells as APCs, CD4 T
cells purified from immunized wild-type mice significantly
proliferated to MOG35–55 when cultured with activated B
cells (Fig. 4 A). Thus, it appears that wild-type APCs are
suppressing CD4 T cell proliferation.
We proceeded to study the effects of IFN-g on prolifer-
ation of activated CD4 T cells in vitro in response to the
priming Ag, MOG35–55. We used a CFSE labeling assay to
specifically measure the kinetics of activated CD4 T cell
proliferation in whole spleen cell culture. Neutralization of
IFN-g significantly increased the percentage of dividing
wild-type CD41CD44hi T cells to MOG35–55, especially at
later time points (Fig. 4 B). Conversely, addition of IFN-g
to IFN-g KO cultures inhibited proliferation of CD41
CD44hi T cells. Thus, IFN-g suppresses proliferation of ac-
tivated CD4 T cells during in vitro Ag restimulation.
Induction of Apoptosis of CD41CD44hi T Cells by IFN-g
In Vitro. We then tested the effect of IFN-g on apoptosis
and death of CD41CD44hi T cells in response to Ag re-
stimulation. IFN-g KO cultures had 63 6 5% live
CD41CD44hi T cells at 60 h of culture compared with
39 6 9% in wild-type cultures (Fig. 5 A). Addition of
IFN-g to IFN-g KO cultures significantly decreased the
number of live CD41CD44hi T cells to 35 6 10%. At
the same time, the percentage of apoptotic and dead
CD41CD44hi T cells increased significantly (Fig. 5 A).
Conversely, neutralization of IFN-g in wild-type cultures
significantly increased the number of live CD41CD44hi T
cells to 54 6 9% and decreased the percentage of apop-
totic and significantly decreased the percentage of dead
CD41CD44hi T cells (Fig. 5 A). A second apoptosis assay,
the TUNEL (TdT-mediated dUTP-biotin nick-end label-
ing) method, was also used to measure in vitro apoptosis of
CD41CD44hi T cells and produced similar results (not
shown). These data indicate that IFN-g induces apoptosis
Figure 3. Enhanced in vivo proliferation and decreased ex vivo apop-
tosis of activated CD4 T cells in IFN-g KO mice with EAE. (A) In vivo
proliferation of CD41CD44hi T cells was measured using BrdU incorpo-
ration assay. A greater percentage of CD41CD44hi T cells in both the
spleen and CNS of IFN-g KO mice incorporated BrdU (Pooled data of
three experiments; n 5 6–8 at each time point). (B) Decreased ex vivo
apoptosis of CD41CD44hi T cells in IFN-g KO mice with EAE. Freshly
isolated spleen cells and CNS mononuclear cells were stained with an-
nexin V–FITC and PI. The figure shows that a smaller percentage of
CD41CD44hi T cells in the spleens of IFN-g KO mice underwent apop-
tosis during the first 3 wk after immunization. In the CNS, at all the time
points assayed, the percentage of apoptotic CD41CD44hi T cells in IFN-g
KO mice was smaller than that in wild-type mice (pooled data of three
experiments; n 5 6–10 at each time point).
Figure 4. Increased in vitro
proliferation of activated CD4 T
cells of IFN-g KO mice to
MOG35–55. (A) CD4 T cells were
purified from spleens of mice im-
munized with MOG35–55 for 2 wk
and cultured in T cell medium
alone or in the presence of OC7–19,
MOG35–55, or Con A with their
own CD4 T cell–depleted spleen
cells or mitomycin C–treated acti-
vated B cells as APCs. The cells
were cultured for 65 h and pulsed
with 0.2 mCi [3H]thymidine for
the last 16 h (two experiments; n 5
4). (B) Kinetic analysis of effects of
IFN-g on CD41CD44hi T cell
proliferation to MOG35–55 in vitro.
CFSE-labeled, purified CD4 T cells from MOG35–55-immunized mice were cultured with MOG35–55 and CD4 T cell–depleted spleen cells as APCs in
the presence of anti–IFN-g or IFN-g. Representative histograms from three experiments (n 5 4) show proliferation of CD41CD44hi T cells.127 Chu et al. Brief Definitive Report
and death of activated CD4 T cells during in vitro restimu-
lation with Ag.
The Suppressive Effect of IFN-g on In Vitro Accumulation of
Activated CD4 T Cells Responding to Ag. We counted the
total number of cells during in vitro restimulation with
MOG35–55 and calculated the absolute number of live
CD41CD44hi T cells. At the end of a 60-h culture, three-
fold more live CD41CD44hi T cells were recovered from
IFN-g KO than from wild-type cultures (Fig. 5 B). Ad-
dition of IFN-g to IFN-g KO cells led to a significant
decrease in the number of live CD41CD44hi T cells. In
contrast, the number of live CD41CD44hi T cells from
wild-type mice decreased with time of culture, but in the
presence of anti-IFN-g, the number of live CD41CD44hi
T cells increased significantly compared with the starting
number (Fig. 5 B).
Discussion
EAE is mediated by autoreactive CD4 T cells (1). It has
been suggested that apoptotic deletion of autoreactive T
cells is related to downregulation of Ag-reactive T cells
during spontaneous recovery from EAE (16, 17). A striking
feature of EAE in IFN-g KO or IFN-gR KO mice is that
the disease is progressive and fatal. Our study focused on the
kinetics of accumulation of activated CD4 T cells in the
CNS of mice deficient in IFN-g production. In IFN-g
KO mice, the activated CD4 T cells persisted in the CNS
in large numbers until the termination of experiments 10
wk after Ag challenge. Our results suggest that IFN-g KO
mice have a defect in eliminating disease-mediating CD4 T
cells. The persistence of large numbers of activated CD4 T
cells in the CNS is the likely cause for the chronic progres-
sive disease course in IFN-g KO mice.
Although several studies have shown that IFN-g inhibits
in vitro proliferation of myelin protein–specific cloned T
cells or T cell lines (6, 7) and in vitro proliferation of pri-
mary lymphocytes from mice with EAE in a bulk cell cul-
ture (2, 8, 9), there have been no reports addressing the
role of IFN-g on in vivo proliferation of CD4 T cells in
mice with EAE. Our data provide critical evidence that
there is increased in vivo proliferation of activated CD4 T
cells in IFN-g KO mice with EAE. However, increased
proliferation of T cells does not necessarily lead to in-
creased accumulation of T cells, as another mechanism for
controlling T cell expansion is increased death. We dem-
onstrate here for the first time that in IFN-g KO mice with
EAE-activated CD4 T cells taken ex vivo from the CNS
and spleen are undergoing decreased apoptosis. We also
demonstrate for the first time that addition of IFN-g to ac-
tivated CD4 T cells from IFN-g KO mice induced apop-
tosis of these cells in response to Ag restimulation. Thus,
the mechanism by which IFN-g inhibits EAE is both by
inhibiting proliferation and by inducing apoptosis of acti-
vated CD4 T cells. The absence of IFN-g results in a mas-
sive accumulation of activated CD4 T cells in the CNS and
spleen after challenge with myelin proteins.
We and others have observed increased inflammation
and increased demyelination in the CNS of IFN-g KO
mice (9), suggesting an IFN-g–independent pathway that
can mediate destruction of myelin. Two recent reports
have demonstrated that there are large numbers of neutro-
phils in the CNS of mice lacking IFN-g or IFN-gR (2, 9).
IFN-g KO mice express chemokines in the CNS that at-
tract neutrophils (9). Another report has shown that deple-
tion of mice with antigranulocyte Ab inhibits EAE in both
SJL and IFN-gR KO mice (18). The relationship between
large numbers of CD4 T cells and neutrophils in the CNS
and the role of each type of cell in mediating myelin de-
struction is not clear. It is possible that the activated CD4 T
cells may produce chemokines that attract neutrophils or
vice versa.
We show in another study, by Dalton et al., published in
this issue that IFN-g is not acting directly on CD4 T cells
but rather is acting indirectly through activated macro-
phages and nitric oxide (NO) (15). Whether activated
macrophages in the spleen or CNS play a role in induction
of apoptosis by IFN-g during EAE is currently under in-
Figure 5. IFN-g suppressed accumulation of live CD41CD44hi T cells in response to MOG35–55. (A) Whole spleen cells from MOG35–55-immunized
mice were cultured with MOG35–55 for 60 h in T cell medium and IL-2 in the presence of anti–IFN-g or IFN-g. The figure shows percentage of live,
dead, and apoptotic CD41CD44hi T cells as determined by annexin/PI assay (pooled data of three experiments; n 5 8 in wild-type and n 5 6 in IFN-g
KO group). (B) Whole spleen cells were cultured and analyzed as described above. Live CD41CD44hi T cells were determined based on the number of
total cells and percentage of live CD41CD44hi T cells (pooled data of two experiments; n 5 4).128 Suppressive Role of IFN-g in Experimental Autoimmune Encephalomyelitis
vestigation. Our preliminary evidence in the EAE model is
that NO may play a role in suppressing proliferation of acti-
vated CD4 T cells. There is in vitro evidence that NO
plays a role in inhibiting Ag-specific T cell proliferation (7,
8) and in inducing apoptosis of encephalitogenic T cell
clones (19). Furthermore, EAE is exacerbated in inducible
NO synthase KO mice (20, 21). We hypothesize that dur-
ing EAE, CD4 T cells making IFN-g infiltrate the CNS
and activate macrophages, microglia, or dendritic cells to
make NO. NO may then induce apoptosis of activated
CD4 T cells, shutting down the immune response and in-
ducing a remission of disease. In the absence of IFN-g, the
mechanism to eliminate activated CD4 T cells is impaired,
the activated CD4 T cells and neutrophils accumulate, and
the disease is chronic and progressive.
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